Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors – results from a randomized double-blind trial-Reference-Cited by-同舟云学术

Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors – results from a randomized double-blind trial

Published:2023-05-07 Issue:7 Volume:62 Page:689-695
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Jørgensen P. L.¹^ORCID,Kreiberg M.¹^ORCID,Jørgensen N.²³^ORCID,Juul A.²³⁴^ORCID,Oturai P. S.⁵^ORCID,Dehlendorff C.⁶^ORCID,Lauritsen J.¹^ORCID,Wagner T.¹,Rosenvilde J.¹^ORCID,Daugaard G.¹⁴^ORCID,Medici C. R.¹,Jørgensen N. R.⁷^ORCID,Bandak M.¹^ORCID

Affiliation:

1. Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark

2. Department of Growth and Reproduction, Copenhagen University hospital - Rigshospitalet, Copenhagen, Denmark

3. International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University hospital - Rigshospitalet, Copenhagen, Denmark

4. Department Clinical Medicine, University of Copenhagen, Denmark

5. Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark

6. Statistics and Dataanalysis, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark

7. Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2207218

Reference28 articles.

1. Guidelines on Testicular Cancer: 2015 Update

2. Testicular cancer

3. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Noncancer Causes of Death in Survivors of Testicular Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Testosterone Replacement in Testicular Cancer Survivors With Treatment-Influenced Hypogonadism: A Systematic Review;Annals of Pharmacotherapy;2024-09-09

2. Insulin-like Factor 3, Basal and Human Chorionic Gonadotropin-Stimulated Testosterone as Biomarkers to Predict the Effect of Testosterone Replacement in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency;Clinical Genitourinary Cancer;2023-08

3. Survivorship – the situation room;Acta Oncologica;2023-07-03